News

Our Healthcare News

Molecular Partners' Collaboration Partner Allergan Exercises Options for Two DARPin Product Candidates

ZURICH-SCHLIEREN, Switzerland—Molecular Partners AG (ticker: MOLN), a clinical-stage biopharmaceutical company developing a new class of drugs known as DARPin® therapies*, today announced that Allergan has…  

Jan 03 2018

Stryker Announces Definitive Agreement to Acquire Entellus

KALAMAZOO, Michigan – – Stryker Corporation (NYSE: SYK) announced today a definitive merger agreement to acquire Entellus Medical, Inc. (NASDAQ: ENTL) for $24.00 per share,…  

Dec 07 2017

Revance’s RT002 Meets Primary and Secondary Endpoints, Achieves 6-Month Duration in Phase 3 Trials

NEWARK, Calif.—(BUSINESS WIRE)—Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions, today announced its next-generation neuromodulator…  

Dec 05 2017

AxoGen, Inc. Announces Proposed Public Offering of Common Stock

ALACHUA, Florida—(GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that…  

Nov 15 2017

EUSA Pharma and AVEO Oncology Announce First Commercial Launch of FOTIVDA (tivozanib)

HEMEL HEMPSTEAD, England & CAMBRIDGE, Massachusetts. – – EUSA Pharma and AVEO Oncology (NASDAQ: AVEO) today announced the first commercial launch of FOTIVDA® (tivozanib) with…  

Nov 15 2017

Otsuka and Proteus Announce First U.S. FDA Approval of a Digital Medicine System:  ABILIFY MYCITE

TOKY, Japan and REDWOOD CITY, California– Otsuka Pharmaceutical Co., Ltd.  (Otsuka) and Proteus Digital Health (Proteus) today announce that the United States Food and Drug…  

Nov 14 2017

Grupo Biotoscana Acquires Laboatorio DOSA

Montevideo, Uruguay - - GBT-Grupo Biotoscana (B3: GBIO33), a leading biopharmaceutical company in Latin America, today announced the acquisition of Laboratorio DOSA S.A., a specialty…  

Nov 13 2017

Biotoscana Announces Launch of ABRAXANE/ABRAXUS in Brazil and Mexico

MONTEVIDEO, Uruguay—BIOTOSCANA INVESTMENTS S.A. (“Company” or “GBT”) (B3: GBIO33), a leading biopharmaceutical company in Latin America, announces to its shareholders and the market in general…  

Nov 01 2017

EW Healthcare Partners Announces the Appointment of Three Senior Executives

NEW YORK, New York—EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the addition of three senior…  

Oct 18 2017